Hengrui Medicine is a leading Chinese national pharmaceutical enterprise dedicated to the research, development, and promotion of innovative and high-quality drugs. The company has established itself as a prominent supplier of a diverse range of pharmaceutical products, including anti-tumor medications, surgical drugs, and interventional imaging products. With a strong commitment to innovation, Hengrui Medicine has achieved significant global recognition, consistently ranking among the top pharmaceutical companies worldwide by prestigious industry publications like PharmExec and Torreya. It plays a crucial role in advancing healthcare through its extensive R&D efforts and broad product portfolio, aiming to provide advanced medical solutions globally.
Through the GEO Score system, we have measured Hengrui Medicine's search visibility on the all AI platforms model.Current GEO Score is 92.0.
Audit Keyword：Hengrui Medicine
Dimension Data Details
Hengrui Medicine's Share of Model (SOM) is 100, higher than 100.0% of competitors
Hengrui Medicine's Ranking is 88, higher than 100.0% of competitors
Hengrui Medicine's Sentiment is 100, higher than 50.0% of competitors
Hengrui Medicine's Accuracy is 100, higher than 25.0% of competitors
Hengrui Medicine's Citation is 45, lower than 100.0% of competitors
Share of Voice (SoV)
Your brand's voice share compared to competitors in AI search
Improvement Opportunities
Your brand outperforms competitor averages across all dimensions
Competitor Comparison
| Brand | GEO Score | SOM | Ranking | Citation | Sentiment | Accuracy | View |
|---|---|---|---|---|---|---|---|
| Hengrui Medicine(Current) | 92.0 | 100.0 | 88.0 | 45.0 | 100.0 | 100.0 | |
| Orient Gene | 73.0 | 77.0 | 49.0 | 33.0 | 100.0 | 100.0 | View |
| Labo Cosmeceutical | 60.0 | 82.0 | 54.0 | 43.0 | 26.0 | 86.0 | View |
| Hightop | 47.0 | 40.0 | 5.0 | 16.0 | 100.0 | 100.0 | View |
| Shenjing Yangyin Capsule | 22.0 | 35.0 | 0.0 | 3.0 | 0.0 | 100.0 | View |